#ESMO25
#ESMO25
Join us for a critical component of #oncology care, family #caregiving. Thrilled to have Dr Tamryn Gray joining us this week.
DM 📨 for a link 🔗 or join our listserv - [email protected] #pallonc #supponc
@crisbergerot.bsky.social
@realbowtiedoc.bsky.social
@tingtingzhang.bsky.social
@fionnualacrowley.bsky.social
Join us for a critical component of #oncology care, family #caregiving. Thrilled to have Dr Tamryn Gray joining us this week.
DM 📨 for a link 🔗 or join our listserv - [email protected] #pallonc #supponc
Big changes in CLL management! Dr. John Allan reviews the latest NCCN Guideline updates, fixed-duration doublets and triplets, and overcoming resistance to BTK inhibitors.
HCP's Register FOR FREE 👉 (USE CODE: ONCOALERT ) buff.ly/OWT0DgG
Big changes in CLL management! Dr. John Allan reviews the latest NCCN Guideline updates, fixed-duration doublets and triplets, and overcoming resistance to BTK inhibitors.
HCP's Register FOR FREE 👉 (USE CODE: ONCOALERT ) buff.ly/OWT0DgG
Learn more about each candidate and make your voice heard: brnw.ch/21wXqu5
Learn more about each candidate and make your voice heard: brnw.ch/21wXqu5
Should we treat Clonal Hematopoiesis (CH)? Dr. Uma Borate explores refining treatment goals for CHIP and Lower-Risk MDS, noting that CH mutations offer a potential 'window for early intervention' before progression to AML. #MDS #CHIP #Leukemia #Hematology
Should we treat Clonal Hematopoiesis (CH)? Dr. Uma Borate explores refining treatment goals for CHIP and Lower-Risk MDS, noting that CH mutations offer a potential 'window for early intervention' before progression to AML. #MDS #CHIP #Leukemia #Hematology
✅ Vote today: www.asco.org/about-asco/a...
✅ Vote today: www.asco.org/about-asco/a...
Thank you @ryannipp.bsky.social !
Mark your calendars for #ASCOQuality in Boston on 10/16-10/17/2026!
@ryannipp.bsky.social
leads us in
@pallonccop.bsky.social
for a summary for #ASCOQLTY25! Join now!!
@tingtingzhang.bsky.social
@fionnualacrowley.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@darcyburbage.bsky.social
@rsedhom.bsky.social
Thank you @ryannipp.bsky.social !
Mark your calendars for #ASCOQuality in Boston on 10/16-10/17/2026!
@therealdsrini.medsky.social
@drdonsdizon.bsky.social
@jasawebb.bsky.social
@djweiner.bsky.social
@stephjantzen.bsky.social
@zachradcliffphd.bsky.social
@therealdsrini.medsky.social
@drdonsdizon.bsky.social
@jasawebb.bsky.social
@djweiner.bsky.social
@stephjantzen.bsky.social
@zachradcliffphd.bsky.social
👉 Post: bit.ly/GeriPalEp378
😀 hosts @alexsmithmd.bsky.social | @ewidera.bsky.social
Read more: brnw.ch/21wWUxx
#ASCOConnection
Read more: brnw.ch/21wWUxx
#ASCOConnection
@ryannipp.bsky.social
leads us in
@pallonccop.bsky.social
for a summary for #ASCOQLTY25! Join now!!
@tingtingzhang.bsky.social
@fionnualacrowley.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@darcyburbage.bsky.social
@rsedhom.bsky.social
@ryannipp.bsky.social
leads us in
@pallonccop.bsky.social
for a summary for #ASCOQLTY25! Join now!!
@tingtingzhang.bsky.social
@fionnualacrowley.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@darcyburbage.bsky.social
@rsedhom.bsky.social
WATCH HERE 👉 cor2ed.com/esmo-2025/br...
Straight from Berlin, Experts share their views on new data on #BreastCancer & #GynOnc
NOW ON DEMAND
WATCH HERE 👉 cor2ed.com/esmo-2025/br...
Straight from Berlin, Experts share their views on new data on #BreastCancer & #GynOnc
NOW ON DEMAND
Missed it live? All the great expert insights from Berlin are now ON DEMAND! Follow for the latest updates and analysis from the meeting
Missed it live? All the great expert insights from Berlin are now ON DEMAND! Follow for the latest updates and analysis from the meeting
WATCH HERE 👉 bit.ly/4qa5j06
Great in-depth reporting on pivotal trials, emerging therapies, and expert insights shaping the future of oncology.
WATCH HERE 👉 bit.ly/4qa5j06
Great in-depth reporting on pivotal trials, emerging therapies, and expert insights shaping the future of oncology.
🎙️Drs Patel The Fellow on Call & @drteplinsky.bsky.social Interlude Podcast
🎙️Drs Patel The Fellow on Call & @drteplinsky.bsky.social Interlude Podcast
@ryannipp.bsky.social
DM for the link or to be added to our mailing list.
@realbowtiedoc.bsky.social
@crisbergerot.bsky.social
@ericroeland.bsky.social
@fionnualacrowley.bsky.social
#pallonc
@ryannipp.bsky.social
DM for the link or to be added to our mailing list.
@realbowtiedoc.bsky.social
@crisbergerot.bsky.social
@ericroeland.bsky.social
@fionnualacrowley.bsky.social
#pallonc
The OncoAlert AF is ready to bring you all the great science coming out of Germany🇩🇪 .
We encourage you to follow these outstanding colleagues, and—as always—OncoAlert will be on the ground reporting in real time on all the latest news and trials. From the podium to you
The OncoAlert AF is ready to bring you all the great science coming out of Germany🇩🇪 .
We encourage you to follow these outstanding colleagues, and—as always—OncoAlert will be on the ground reporting in real time on all the latest news and trials. From the podium to you
meetings.asco.org/2025-asco-qu...
@ascocancer.bsky.social
#PallOnc #SuppOnc #CancerResearch
meetings.asco.org/2025-asco-qu...
@ascocancer.bsky.social
#PallOnc #SuppOnc #CancerResearch